Biographies

Geoffrey Odell

Geoff has worked for Novartis for 7 years. He joined the Pharmaceutical division just after the Ciba/Sandoz merger in 1997 with responsibility for the servers, networks & desktop computing environments. In 2001 he was tasked with supporting the U.S. Marketing & Sales systems, supporting 6500 representatives. In 2002 he moved over to the Research technology organization, in a dual role of integrating the 3 Novartis Corporate Research sites with the new Research organization (NIBR), while also having accountability for the emerging collaborative technology portfolio for Research.

Prior to working for Novartis, Geoff worked in roles of increasing responsibility at in the Financial services industry at Bankers Trust & Wasserstein Perella. Prior to this he worked at Pfizer & American Home Products.

Geoff graduated with a Bachelors degree in Applied Zoology from the University of Wales in 1978.

Novartis is a world leader in the research and development of products to protect and improve health and well-being. Novartis was created in 1996 from the merger of the Swiss companies, Ciba and Sandoz.

Our core businesses are in pharmaceuticals, consumer health, generics, eye-care, and animal health. Our name, derived from the Latin novae artes, meaning “new skills,” reflects our commitment to focus on research and development to bring innovative new products to the communities we serve.

In 2003, the Group's businesses achieved sales of USD 24.9 billion and a net income of USD 5.0 billion. The Group invested approximately USD 3.8 billion in research and development (R&D). Headquartered in Basel, Switzerland, Novartis Group companies employ about 78,500 people and operate in over 140 countries around the world.
www.novartis.com